Patent ID: 11952425
Assignee: TRUSTEES OF DARTMOUTH COLLEGE
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 18:
19. The method of claim 18, wherein (i) the effective amount is an amount effective to kill or reduce, in a subject, growth of cells expressing B7 homolog 6; (ii) the effective amount is an amount effective to kill or reduce, in a subject, growth of cancer cells expressing B7 homolog 6; (iii) the subject has myeloid leukemia, acute nonlymphocytic leukemia, acute lymphoblastic leukemia, B-cell lymphoma, breast cancer, cervical cancer, clear cell renal cell carcinoma, dermatofibrosarcoma protuberans, gastric sarcoma, gastrointestinal stromal tumor, glioblastoma, leiomyosarcoma, invasive ductal breast carcinoma, malignant fibrous histiocytoma, melanoma, ovarian serous surface papillary carcinoma, pancreatic cancer, prostate cancer, T-cell acute lymphoblastic leukemia or T-cell lymphoma; (iv) the effective amount is an amount effective to induce an immune response, in the subject, against cells expressing B7 homolog 6; (v) the subject has an autoimmune disorder; (iv) the subject has Sjogren's syndrome; and/or (vi) the method includes co-administering a second therapeutic agent.